Background: Plasma C-terminal atrial natriuretic peptide (C-ANP), N-terminal ANP (N-ANP),
and brain natriuretic peptide (BNP) have diagnostic utility in detecting left ventricular …

Objectives: Using a prospective study design, we assessed the value of brain natriuretic
peptide (BNP) to identify patients with heart failure who have an increased risk of …

Background: Brain natriuretic peptide (BNP) levels have been used to assess clinical status
and predict prognosis of patients with chronic heart failure (CHF). However, BNP levels can …

Background: We compared the diagnostic accuracy of brain natriuretic peptide (BNP) and
amino-terminal proBNP (NT-proBNP) for diagnosis of preclinical and mild heart failure (HF) …

Background: Brain natriuretic peptide (BNP) levels predict prognosis in heart failure patients.
We aimed to evaluate if serial measurements of BNP can give additional prognostic …

Background The diagnosis of heart failure is difficult, with both overdiagnosis and
underdiagnosis occurring commonly in practice. Natriuretic peptides have been proposed …

Background: Progression of heart failure is related to ventricular remodeling, a process
associated to neurohormonal activation. Brain natriuretic peptide (BNP), a member of the …

Aim Plasma brain natriuretic peptide (BNP) concentrations are known to have high
sensitivity and specificity in the diagnosis of heart failure in newly symptomatic patients. The …

Background Cardiac natriuretic peptides are activated in heart failure. However, their
diagnostic and prognostic values have not been compared under the routine conditions of …

Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are important biomarkers
in the diagnosis and risk stratification for heart failure (HF). These peptides are synthesised …